A physiological model for simulation of benzene metabolism by rats and mice

Toxicology and Applied Pharmacology
M A MedinskyR F Henderson


Studies conducted by the National Toxicology Program on the chronic toxicity of benzene indicated that B6C3F1 mice are more sensitive to the toxic effects of benzene than are F344 rats. A physiological model was developed to describe the uptake and metabolism of benzene in rats and mice and to determine if the observed differences in toxic effects could be explained by differences in the pathways for metabolism of benzene or by differences in uptake of benzene. Major pathways for elimination of benzene included metabolism to hydroquinone glucuronide or hydroquinone sulfate, phenyl glucuronide or phenyl sulfate, muconic acid, and prephenyl mercapturic acid or phenyl mercapturic acid. Model simulations for total benzene metabolized and for profiles of benzene metabolites were conducted for oral or inhalation exposure and compared to data for urinary excretion of benzene metabolites after exposure of rats and mice to [14C]- or [3H]-benzene by inhalation or gavage. Results for total amount of benzene metabolized, expressed per kilogram body weight, indicated that for inhalation exposure concentrations up to 1000 ppm, mice metabolized at least two to three times as much benzene as did rats. Simulations of oral exposure to benzene re...Continue Reading


Sep 1, 1979·Journal of Toxicology and Environmental Health·D SammettR Snyder
Oct 1, 1987·Toxicology and Applied Pharmacology·D A EastmondR D Irons
Jul 1, 1988·Journal of Analytical Toxicology·W E BechtoldR F Henderson
Jan 1, 1987·Critical Reviews in Toxicology·G F Kalf
Jun 15, 1988·Toxicology and Applied Pharmacology·P J SabourinR F Henderson
Nov 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·L LatrianoG Witz
Oct 1, 1985·Fundamental and Applied Toxicology : Official Journal of the Society of Toxicology·J S DutcherL S Birnbaum
Oct 1, 1973·Toxicology and Applied Pharmacology·O G RaabeM I Tillery
Mar 30, 1984·Toxicology and Applied Pharmacology·J C Ramsey, M E Andersen
May 1, 1981·Critical Reviews in Toxicology·M E Andersen
Sep 15, 1980·Toxicology and Applied Pharmacology·L S BirnbaumH B Matthews
Jul 21, 2011·Journal of Pharmacology & Pharmacotherapeutics·Pronobesh ChatopadhyayLokendra Singh

❮ Previous
Next ❯


Jan 1, 1990·International Archives of Occupational and Environmental Health·P DucosC Maire
Jan 1, 1992·Archives of Toxicology·W E BechtoldR F Henderson
Dec 31, 2009·Bulletin of Mathematical Biology·Cammey C ManningHien T Tran
Dec 28, 1995·Toxicology·M A MedinskyP M Schlosser
Jul 1, 1990·Toxicology Letters·K J PurcellC C Travis
Apr 7, 1995·Journal of Chromatography. B, Biomedical Applications·T RuppertF Adlkofer
Aug 1, 1995·Toxicology in Vitro : an International Journal Published in Association with BIBRA·J M Frazier
Feb 28, 2004·Environment International·F FabiettiM R Sprechini
Mar 1, 2004·Environmental Toxicology and Pharmacology·James E DennisonRaymond S H Yang
Mar 24, 2004·Mutation Research·Won-A JooChan-Wha Kim
Dec 13, 1996·Journal of Chromatography. B, Biomedical Applications·T EinigW Dehnen
May 8, 2004·Journal of Toxicology and Environmental Health. Part a·Karla D ThrallMelissa R Kania
Sep 11, 1991·Risk Analysis : an Official Publication of the Society for Risk Analysis·L A Cox
Dec 1, 1991·Risk Analysis : an Official Publication of the Society for Risk Analysis·R C SpearS Selvin
Jun 1, 1992·Risk Analysis : an Official Publication of the Society for Risk Analysis·T J WoodruffR C Spear
Sep 11, 1992·Risk Analysis : an Official Publication of the Society for Risk Analysis·L A Cox, P F Ricci
Jun 24, 1998·Risk Analysis : an Official Publication of the Society for Risk Analysis·E A BrownJ W Fisher
Feb 24, 1998·Annals of the New York Academy of Sciences·M S Legator
Oct 24, 2001·Environmental Health Perspectives·Y S LinD Wypij
Dec 1, 1994·Environmental Health Perspectives·D KrewskiM E Andersen
Nov 1, 1994·Environmental Health Perspectives·J A BondL Recio
Dec 1, 1996·Environmental Health Perspectives·R F Henderson
Dec 1, 1996·Environmental Health Perspectives·M A MedinskyP M Schlosser
Dec 1, 1996·Environmental Health Perspectives·F Y BoisM T Smith
Apr 1, 1993·Environmental Health Perspectives·R SnyderB D Goldstein
Oct 31, 2015·Annual Review of Pharmacology and Toxicology·Linda S Birnbaum
May 6, 2008·Chemico-biological Interactions·Barbara A WetmoreDavid C Dorman
Aug 1, 1991·Toxicology and Applied Pharmacology·F Y BoisR C Spear
Jun 1, 1992·Toxicology and Applied Pharmacology·P J SabourinR F Henderson
Jan 1, 1994·Critical Reviews in Toxicology·R Snyder, G F Kalf
Nov 22, 2008·Toxicology and Industrial Health·S WilburO Faroon

❮ Previous
Next ❯

Related Concepts

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.


Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.


Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2021 Meta ULC. All rights reserved